Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Preclinical Efficacy of MEK Inhibition in Nras Mutant Acute Myeloid Leukemia
HTML
Details
Locations
Year:
2014
Type:
article
Source:
Blood
DOI:
10.1182/blood.v124.21.3753.3753
Authors:
Michael R. Burgess,
Eugene Hwang,
Ari J Firestone,
Tannie Huang,
Jin Xu,
Johannes Zuber,
Natacha Bohin,
Tiffany Wen,
Scott C. Kogan,
Kevin M. Haigis,
Scott W. Lowe,
Kevin Shannon,
Qing Li
show all 13
Institutions:
University of California, San Francisco,
Research Institute of Molecular Pathology,
University of Michigan,
Massachusetts General Hospital,
Memorial Sloan Kettering Cancer Center
Language:
English
Topic:
Acute Myeloid Leukemia Research
Subfield:
Hematology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W3021932481
FWCI:
0.204
Cites:
38
Cited by:
2
Related to:
10